The Asian Scientist 100
Emi Ito
Institution
Osaka University
Country
Japan
Field
Life Sciences
Ito was awarded the 2023 JSPS Ikushi Prize by the Japan Society for the Promotion of Science for her research on unraveling the role of host-derived metabolites in the development of innate-type T cells.
(Photo: Osaka University)
AWARDS
- 2023 JSPS Ikushi Prize
Related articles
Flu Vaccine Candidate May Have Broad Spectrum Efficacy
Researchers have designed a new drug to safeguard against epidemic and pandemic influenza virus strains.
WHO: Everything You Need To Know About The H7N9 Influenza Virus
The World Health Organization has released a FAQ list answering some questions relating to the H7N9 influenza A virus outbreak in China.
Veredus’ VereFlu Chip Detects H7N9 Bird Flu
Its VereFlu lab-on-a-chip platform has been shown to detect the H7N9 avian flu subtype that is responsible for the recent flu outbreak in China.
New H7N9 Bird Flu Strain Adapted To Humans, Study
A genetic analysis of the avian flu virus responsible for at least 11 human deaths in China portrays a virus evolving to adapt to human cells.
Double Dose Of Tamiflu No More Effective In Severe Flu, Study
Double doses of the antiviral drug Tamiflu to patients with severe flu offers no clinical advantage over the standard dose, says a new study.
Studying Animals To Improve Human Health
Research into animals, both common and obscure, are yielding insights into human health that are not always expected, writes Shuzhen Sim.
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
A gene variant commonly found in individuals of East Asian descent, but not in African or European people, may be responsible for resistance to targeted cancer drugs used to treat certain types of leukemia and lung cancer.
Experts Discuss Latest In Hematology Research At Suntec Singapore
Hematology experts gathered at Suntec Singapore from March 29-30, 2014 to discuss the latest in blood disorders research.
The One-Two Punch Of DNA Damage & Repair Inhibition
Scientists have found a drug that not only causes DNA damage but also prevents repair, enhancing its potency in treating cancer.